Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

DaVita Inc. (DVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
86.31-1.18 (-1.35%)
At close: 04:00PM EDT
86.60 +0.29 (+0.34%)
After hours: 06:10PM EDT
Advertisement

DaVita Inc.

2000 16th Street
Denver, CO 80202
United States
720 631 2100
https://www.davita.com

Sector(s)Healthcare
IndustryMedical Care Facilities
Full Time Employees69,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Javier J. RodriguezCEO & Exec. Director3.3M5.95M1971
Mr. Joel AckermanCFO & Treasurer1.43M9.33M1965
Ms. Kathleen Alyce WatersChief Legal & Public Affairs Officer1.28M1.15M1968
Mr. James O. HeartyChief Compliance Officer891.58k150.51k1969
Mr. Michael David StaffieriChief Operating Officer of Kidney Care1.98M2.52M1974
Mr. John D. WinstelChief Accounting OfficerN/AN/A1971
Mr. Jim GustafsonVP of Investor RelationsN/AN/AN/A
Mr. Kenneth Gardner SmithChief People OfficerN/AN/A1981
Mr. Atul MathurExec. VP of Global OperationsN/AN/AN/A
Dr. Abdulkareem Alsuwaida FRCPC, M.D., MScChief Medical Officer - Saudi OperationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Corporate Governance

DaVita Inc.’s ISS Governance QualityScore as of September 1, 2022 is 3. The pillar scores are Audit: 6; Board: 3; Shareholder Rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement